Home / Biotechnology / Proteomics

Proteomics Market By Component Type (Instrumentation Technology, Consumables And Reagents, Services), By Application Type (Drug Discovery, Clinical Diagnostics) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Industry Outlook

The global proteomics market was worth $15.1 billion in 2017 and is expected to grow at a compound annual growth rate (CAGR) of 10.4% from 2018 to 2026. The market is fueled by the growing importance of sensitive and accurate diagnosis offered by proteomics in personalized medicine. Detailed study of proteins provides superior understanding and opportunities for the development of drugs that can target disease pathways more efficiently. The emergence of new protein biomarkers during disease progression, as well as the subsequent development of novel drugs for various chronic diseases, has strengthened the global proteomics market. Many studies have proven that proteomics analysis provides a deeper understanding of disease progression and mechanism as compared to genetic studies; hence, proteomics has proven to be the gold standard in developing novel drugs for diseases such as cancer, cardiovascular diseases, and neurodegenerative diseases. Supportive government funding and initiatives from private research organizations for proteomics research, the development of novel technologies such as mass spectrometry and chemoproteomics, and the growing focus of biopharmaceutical companies on novel drug discoveries have further assisted the growth of the global proteomics market. However, the stringent regulatory scenario, lack of qualified and skilled research infrastructure, and high cost associated with proteomics studies are the major hindrances faced by the proteomics market.

Market Synopsis

Growing Applications of Proteomics in Drug Discovery Pave the Future of the Proteomics Market

A better understanding of the proteome has led to the development of advanced sequencing methods and improved technologies that have assisted in the expansion of proteomics applications. The discovery of protein biomarkers has enabled the development of novel drugs. Biomarker-based drug discovery is the main area of focus due to its efficiency in treating chronic diseases. Technological advancements in instrumentation and the development of biochip devices will further create milestones in drug discovery and clinical diagnosis. Clinical diagnostics held the largest market in the proteomics market in terms of application. Moreover, it is further projected to foresee lucrative growth during the forecast period due to the development of cancer biomarkers and other biomarkers in various diseases. Personalized medicine will assist the growth of the drug discovery market during the forecast period.

North America Dominated the Global Proteomics Market

Because of the location of major biotechnology and pharmaceutical companies conducting proteomics research, North America held the largest regional market for the global proteomics market in 2017. Moreover, North America has been the spearhead in the development of novel drugs for the treatment of various chronic diseases, such as cancer, neurological, and cardiovascular diseases. The U.S. held the lion’s share in North America due to substantial funding from government bodies to foster the growth of proteomics research in drug discovery and clinical diagnostics. Europe held the second-largest share in the global proteomics market, attributed to the significant government funding in the region. Furthermore, the region has been an early adopter of novel diagnostics and drugs owing to the growing prevalence of chronic diseases in the region. Asia Pacific is projected to exhibit the highest growth rate during the forecast period owing to rigorous growth in biopharmaceutical R&D in China, South Korea, and India. Outsourcing and foreign investments in the region further make the region lucrative for proteomics research.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments was calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The proteomics market report provides quantitative analysis as well as current market trends. The market is segmented based on component type, application, and geography.

The market is studied in order to understand the current dynamics and future trends in the global proteomics market. The study includes market size and forecasts for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rates (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year. The key players currently engaged in the proteomics market include Bio-Rad Laboratories Inc., ThermoFisher Scientific, Waters Corporation, Merck KGaA, PerkinElmer Inc., Bruker Corporation, Caprion Proteomics Inc., GE Healthcare, Shimadzu Biotech, among others. The companies are engaged in the development of various reagents and technologies that assist the efficacy of proteomics research. Mergers and acquisitions of smaller biotechnology companies by biopharmaceutical giants are the major trends observed in the proteomics market.

Key questions are answered in this report.

  • How will the global proteomics market perform during the forecast period from 2018 to 2026?
  • What are the latest trends in the proteomics market and the most valuable opportunities for key players?
  • Who are the leading players in the global proteomics market?
  • Which is the leading and fastest-growing region in the global proteomics market?
  • What are the drivers and restraints governing the global proteomics market?
  • What are the applications of proteomics, and which is the currently leading application?

 Frequently Asked Questions:

The market for Proteomics is expected to reach US$ 15.1 Bn in 2026.

The Proteomics market is expected to see significant CAGR growth over the coming years,at 10.4%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Thermo Fisher Scientific Inc.,Agilent Technologies, Inc.,Bio-Rad Laboratories Inc.,Merck KGaA,Danaher Corporation are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Oct 2018
Category:  Biotechnology
Report ID:   59408
Report Format:   PDF
Pages:   120
Rating:    4.4 (69)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support